Aimovig Migraine Tracker
OVERVIEW
Aimovig is a new prescription medicine used to help prevent or reduce migraines in adults. It is the first and only FDA-approved treatment that blocks the CGRP receptor in order to prevent migraines. For many patients, Aimovig has been shown to cut monthly migraine days by 50% or more. In an 11-month cohort study of Aimovig patients, anecdotal feedback revealed that patients need a way to quantify the positive effects of the treatment.
OBJECTIVEGage the usefulness of a text messaging and journal program meant to help migraine patients get a fuller picture of how their treatment is working for them.
KEY RESULTSLearn if migraine patients value journaling as a tool to help them understand their condition
Learn the value of a text messaging program as a means of tracking their migraines
ROLEProduct Designer, Visual Designer
May 2019 - May 2020
The Users
The team conducted a research study focused on female patients from 28-55 years old, suffering from chronic and episodic migraines.
ELIGIBILITY FOR STUDY:Received a diagnosis of chronic or episodic migraine from a physician.
Has been prescribed and filled an anti-CGRP for migraine.
Has access to a smartphone with SMS and is willing to receive daily SMS messages.
Satisfaction with their treatment was very polarized, success being defined as migraine-free days and failure as migraine occurrence, which created feelings of hopelessness. Days with migraine completely threw off their overall perception of treatment. Patients who achieved success with their treatment struggled to redefine what day-to-day life came to mean without the presence of migraine.
Design Approach
Building off of key findings from user research, the team decided they wanted to design the journal program with the following goals:
Increase patient awareness of their condition and knowledge of the individual symptoms.
Encourage patients to reflect on/think about their symptoms, the triggers, the pattern & trends in their symptoms, the good & bad days, and the link between the symptoms and taking their medication.
Inspire patients to write down their findings, thoughts, and questions in a relevant place.
Enable patients to share their symptom data and trends with their HCPs and loved ones.
Data visualization research
Data visualization research
Data visualization research
Data visualization research
The Process
After six weeks in the study, the team explored participants’ views on several journal designs.
DISCOVERIESTracking gave participants a more accurate understanding of their monthly migraine days and confidence to discuss this information with their providers.
Most participants described this as legitimizing because they were able to provide “concrete numerical evidence” to their providers about how their medications are working.
Final Design
After several rounds of feedback from our participants, we found that having their data automatically compiled in the summary message and journal report was highly valued because it visualized their monthly migraine days “in black and white.”
